Product NDC: | 16590-871 |
Proprietary Name: | ZANAFLEX |
Non Proprietary Name: | TIZANIDINE HYDROCHLORIDE |
Active Ingredient(s): | 4 mg/1 & nbsp; TIZANIDINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16590-871 |
Labeler Name: | STAT RX USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021447 |
Marketing Category: | NDA |
Start Marketing Date: | 20020829 |
Package NDC: | 16590-871-62 |
Package Description: | 84 CAPSULE in 1 BOTTLE (16590-871-62) |
NDC Code | 16590-871-62 |
Proprietary Name | ZANAFLEX |
Package Description | 84 CAPSULE in 1 BOTTLE (16590-871-62) |
Product NDC | 16590-871 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TIZANIDINE HYDROCHLORIDE |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20020829 |
Marketing Category Name | NDA |
Labeler Name | STAT RX USA LLC |
Substance Name | TIZANIDINE HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |